140 related articles for article (PubMed ID: 17022536)
1. [Postprandial hypoglycemia].
Mori Y
Nihon Rinsho; 2006 Sep; Suppl 3():224-9. PubMed ID: 17022536
[No Abstract] [Full Text] [Related]
2. [Therapies for newly-onset diabetic patients].
Kawamori R
Nihon Rinsho; 2005 Feb; 63 Suppl 2():525-32. PubMed ID: 15779435
[No Abstract] [Full Text] [Related]
3. [Impaired glucose tolerance in dumping syndrome].
Itoh H
Nihon Rinsho; 2005 Feb; 63 Suppl 2():295-9. PubMed ID: 15779391
[No Abstract] [Full Text] [Related]
4. [Effects of nateglinide in impaired glucose tolerance subjects].
Hirose T
Nihon Rinsho; 2005 Feb; 63 Suppl 2():438-43. PubMed ID: 15779419
[No Abstract] [Full Text] [Related]
5. Concurrent Therapy with a Low-carbohydrate Diet and Miglitol Remarkably Improved the Postprandial Blood Glucose and Insulin Levels in a Patient with Reactive Hypoglycemia due to Late Dumping Syndrome.
Hirose S; Iwahashi Y; Seo A; Sumiyoshi M; Takahashi T; Tamori Y
Intern Med; 2016; 55(9):1137-42. PubMed ID: 27150868
[TBL] [Abstract][Full Text] [Related]
6. Seven-day subcutaneous continuous glucose monitoring demonstrates that treatment with acarbose attenuates late dumping syndrome in a woman with gastrectomy for gastric cancer.
Buscemi S; Mattina A; Genova G; Genova P; Nardi E; Costanzo M
Diabetes Res Clin Pract; 2013 Jan; 99(1):e1-2. PubMed ID: 23146372
[No Abstract] [Full Text] [Related]
7. [Pharmacological treatment of postprandial hyperglycemia in hypertensive patients with type 2 diabetes mellitus].
Yamada K
Nihon Rinsho; 2003 Jul; 61(7):1219-23. PubMed ID: 12877088
[TBL] [Abstract][Full Text] [Related]
8. Nateglinide and acarbose for postprandial glucose control after optimizing fasting glucose with insulin glargine in patients with type 2 diabetes.
Kim MK; Suk JH; Kwon MJ; Chung HS; Yoon CS; Jun HJ; Ko JH; Kim TK; Lee SH; Oh MK; Rhee BD; Park JH
Diabetes Res Clin Pract; 2011 Jun; 92(3):322-8. PubMed ID: 21376417
[TBL] [Abstract][Full Text] [Related]
9. Nateglinide improves early insulin secretion and controls postprandial glucose excursions in a prediabetic population.
Saloranta C; Guitard C; Pecher E; De Pablos-Velasco P; Lahti K; Brunel P; Groop L
Diabetes Care; 2002 Dec; 25(12):2141-6. PubMed ID: 12453951
[TBL] [Abstract][Full Text] [Related]
10. Favorable effects of early insulin secretion by nateglinide on postprandial hyperlipidemia in patients with type 2 diabetes.
Ai M; Tanaka A; Ogita K; Shimokado K
Diabetes Care; 2006 May; 29(5):1180. PubMed ID: 16644666
[No Abstract] [Full Text] [Related]
11. [Pathophysiological conditions progressing from impaired glucose tolerance: coronary artery disease (ischemic heart disease)].
Tomono S; Uchiyama T; Ohyama Y
Nihon Rinsho; 2005 Feb; 63 Suppl 2():255-9. PubMed ID: 15779382
[No Abstract] [Full Text] [Related]
12. Beneficial metabolic effects of nateglinide versus acarbose in patients with newly-diagnosed type 2 diabetes.
Gao HW; Xie C; Wang HN; Lin YJ; Hong TP
Acta Pharmacol Sin; 2007 Apr; 28(4):534-9. PubMed ID: 17376293
[TBL] [Abstract][Full Text] [Related]
13. Improved post-prandial ghrelin response by nateglinide or acarbose therapy contributes to glucose stability in Type 2 diabetic patients.
Zheng F; Yin X; Lu W; Zhou J; Yuan H; Li H
J Endocrinol Invest; 2013; 36(7):489-96. PubMed ID: 23324437
[TBL] [Abstract][Full Text] [Related]
14. [NAVIGATOR trial (nateglinide)].
Tsujii S
Nihon Rinsho; 2005 Feb; 63 Suppl 2():483-7. PubMed ID: 15779426
[No Abstract] [Full Text] [Related]
15. Improvement of glucose tolerance by nateglinide occurs through enhancement of early phase insulin secretion.
Uto Y; Teno S; Iwamoto Y; Omori Y; Takizawa T
Metabolism; 2002 Jan; 51(1):20-4. PubMed ID: 11782867
[TBL] [Abstract][Full Text] [Related]
16. [Glinide(s), sulfonylurea(s)].
Arakawa M; Hirose T
Nihon Rinsho; 2006 Nov; 64(11):2107-12. PubMed ID: 17087304
[TBL] [Abstract][Full Text] [Related]
17. Differential therapeutic effects of nateglinide and acarbose on fasting and postprandial lipid profiles: a randomized trial.
Zhou J; Deng Z; Lu J; Li H; Zhang X; Peng Y; Mo Y; Bao Y; Jia W
Diabetes Technol Ther; 2015 Apr; 17(4):229-34. PubMed ID: 25781235
[TBL] [Abstract][Full Text] [Related]
18. [Significance of insulin secretion pattern lectured by "glinides" in the treatment of postprandial hyperglycemia].
Hirose T
Nihon Rinsho; 2005 Dec; 63(12):2237-44. PubMed ID: 16363700
[TBL] [Abstract][Full Text] [Related]
19. Acarbose attenuates hypoglycemia from dumping syndrome in an elderly man with gastrectomy.
Yamada M; Ohrui T; Asada M; Ishizawa K; Ebihara S; Arai H; Sasaki H
J Am Geriatr Soc; 2005 Feb; 53(2):358-9. PubMed ID: 15673372
[No Abstract] [Full Text] [Related]
20. [Effects of acarbose, alpha-glucosidase inhibitor in treatment of impaired glucose tolerance].
Sakamoto N; Tajima N
Nihon Rinsho; 2005 Feb; 63 Suppl 2():451-6. PubMed ID: 15779421
[No Abstract] [Full Text] [Related]
[Next] [New Search]
